SCHEMBL29587115

SCHEMBL29587115

COc1c(F)cc(C(=O)N2CCc3nc(-c4ccccn4)ncc3C2)cc1F

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.54
KDR P35968 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21326027 1.00 PDGFRB (0.54) PDGFRBKDR
SCHEMBL21325978 0.90 PDGFRB (0.65) PDGFRBKDR
SCHEMBL21325988 0.89 NPC1 (0.58) PDGFRBKDR
SCHEMBL29587434 0.89 NPC1 (0.58) PDGFRBKDR
SCHEMBL21326002 0.88 PDGFRB (0.61) PDGFRBKDR
SCHEMBL29587423 0.88 PDGFRB (0.61) PDGFRBKDR
SCHEMBL29587388 0.87 PDGFRB (0.54) PDGFRBKDR
SCHEMBL21326063 0.87 PDGFRB (0.54) PDGFRBKDR
SCHEMBL21326015 0.87 PDGFRB (0.53) PDGFRBKDR
SCHEMBL29587270 0.87 PDGFRB (0.53) PDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110088103-B Novel tetrahydropyridopyrimidine compounds for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2022-04-12 CN claimed
CN-110088103-B Novel tetrahydropyridopyrimidine compounds for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2022-04-12 CN disclosed